LATEST HEALTH NEWS
Researchers participated in international Phase 3 clinical trial leading to FDA approval of TRIKAFTA (Regd) (elexacaftor/tezacaftor/ivacaftor) for cystic fibrosis patients ages 6 through 11.
from Medindia Health News https://ift.tt/3zaRUKt
No comments
Thanks for comment via will connect you within 24 hours.